·   Log in

Archive for April 24th, 2010

Pyronaridine-artesunate combo pill Pyramax by Korean firm Shin Poong is as effective as Coartem, claims study

Saturday, April 24, 2010 7:44

Pyronaridine-artesunate combination pill Pyramax is as effective against falciparum malaria as the current gold standard anti-malarial combo artemether-lumefantrine which is marketd by Novartis under the brand name Coartem, according to a new study in the leading medical journal Lancet.

This was posted under category: health  |  Read Full Story  |  2 Comments
Tagged with:

Liraglutide injection (Victoza) more effective than sitaglipin (Januvia) to control blood glucose; has less risk of hypogycemia: Study

Saturday, April 24, 2010 6:45

Novo Nordisk's liraglutide (Victoza) injection has been found more effective in controlling blood glucose levels and safer than Merck Inc's anti-diabetic oral pill sitagliptin (Januvia) in clinical studies.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with: ,

Piramal beefs up anaesthetics portfolio by acquiring Bharat Serums’ injectables business

Saturday, April 24, 2010 6:03

Piramal Healthcare Limited, one of India’s largest pharmaceutical and healthcare companies, has acquired Bharat Serums and Vaccines Limited's injectible anaesthetic products business.

This was posted under category: Featured, Industry  |  Read Full Story  |  0 Comments

AFFiRiS’s Alzheimer’s vaccine AD02 to be studied in European patients

Saturday, April 24, 2010 5:34

AFFiRiS AG will test its Alzheimer's vaccine candidate AD02 in Austria and five other European countries as part of a multicentre phase II clinical study.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with: ,